Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Belgian plasmapheresis programme

C Vermylen

    Developments in Biological Standardization
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Belgium achieves national self-sufficiency in plasma-derived therapeutics through regular, non-remunerated donations via double plasmapheresis. This model maximizes plasma collection while avoiding red blood cell wastage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Contribution of plasma membrane lipid domains to red blood cell (re)shaping.

    Scientific reports·2017
    Same author

    Computational and molecular approaches for predicting unreported causal missense mutations in Belgian patients with haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia·2011
    Same author

    Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.

    Medecine tropicale : revue du Corps de sante colonial·2011
    Same author

    Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program.

    Bone marrow transplantation·2011
    Same author

    Neonatal acute myeloid leukemia in an infant whose mother was exposed to diethylstilboestrol in utero.

    Pediatric blood & cancer·2009
    Same author

    Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.

    Vaccine·2007
    Same journal

    International challenges and public policy issues.

    Developments in biological standardization·2000
    Same journal

    Standardisation and licensing of combination vaccines based on DTP.

    Developments in biological standardization·2000
    Same journal

    The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.

    Developments in biological standardization·2000
    Same journal

    Cytokine and growth factor standardization: the need for research to answer modern issues.

    Developments in biological standardization·2000
    Same journal

    Alternatives to the use of animals for bacterial toxins and antitoxins.

    Developments in biological standardization·2000
    Same journal

    Cell substrates: lessons learned and challenges remaining.

    Developments in biological standardization·2000
    See all related articles

    Area of Science:

    • Transfusion Medicine
    • Public Health Policy
    • Biologics Manufacturing

    Background:

    • Belgium collects 75,000-80,000 liters of plasma annually from 6,000 non-remunerated donors.
    • Plasma is collected via double plasmapheresis with donations every two weeks.
    • An additional 5,000 liters/10^6 inhabitants is recovered from whole blood donations.

    Purpose of the Study:

    • To describe Belgium's national plasma self-sufficiency program.
    • To present the model as a unique approach to plasma collection.
    • To highlight the avoidance of red cell wastage and reliance on non-remunerated donors.

    Main Methods:

    • Regular plasma collection through double plasmapheresis.
    • Recovery of plasma from whole blood donations.

    Related Experiment Videos

  • Analysis of total plasma collected per capita.

    • Main Results:

    • Belgium collects 13,000 liters of plasma/10^6 inhabitants annually.
    • This volume meets national requirements for albumin, coagulation factors, and immunoglobulins.
    • The program operates entirely on non-remunerated donors.

    Conclusions:

    • Belgium's plasma collection program ensures national self-sufficiency in essential plasma-derived products.
    • The model effectively utilizes non-remunerated donors and minimizes wastage.
    • This approach offers a unique, sustainable solution for national plasma needs.